namaxir 22,5 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
actavis group ptc ehf. - metotreksat - raztopina za injiciranje - metotreksat 22,5 mg / 1 brizga - metotreksat
xeljanz
pfizer europe ma eeig - tofacitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 in 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
doksivibra 100 mg disperzibilne tablete
pfizer luxembourg sarl - doksiciklin - disperzibilna tableta - doksiciklin 100 mg / 1 tableta - doksiciklin
metotreksat ebewe 20 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 20 mg / 1 ml - metotreksat
metotreksat ebewe 20 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 20 mg / 1 ml - metotreksat
metotreksat actavis 25 mg/ml raztopina za injiciranje/infundiranje
actavis group ptc ehf. - metotreksat - raztopina za injiciranje/infundiranje - metotreksat 25 mg / 1 ml - metotreksat
metotreksat ebewe 10 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 10 mg / 1 ml - metotreksat
metotreksat ebewe 100 mg/ml koncentrat za raztopino za infundiranje
ebewe pharma - metotreksat - koncentrat za raztopino za infundiranje - metotreksat 100 mg / 1 ml - metotreksat
metotreksat ebewe 20 mg/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
ebewe pharma - metotreksat - raztopina za injiciranje v napolnjeni injekcijski brizgi - metotreksat 20 mg / 1 ml - metotreksat
roaccutane 10 mg mehke kapsule
roche d.o.o. - izotretinoin - kapsula, mehka - izotretinoin 10 mg / 1 kapsula - izotretinoin